Hemagglutination inhibition (HI) tests against whole virus (WV) 
The relatively inexpensive and easily performed influenza virus hemagglutination inhibition (HI) test has been widely used for serodiagnosis of infection, measurement of serum antibody prevalence, and determination of vaccine-induced antibody responses (16) . However, the existence of virus strains which are poorly reactive in HI tests has been recognized with all influenza A virus subtypes that have caused epidemics in humans (6, 7, 13; unpublished observations), and many investigators have observed the same problem with influenza B viruses in recent years (2, 5, 9, 15, 17, 18, 20) . A means for increasing the reactivity of many influenza virus antigens in HI tests is ether treatment of the virus; this effect of ether treatment has been described for HlNl viruses (11, 13) , H2N2 viruses (19) , one of the equine influenza viruses (1) , and recently prevalent influenza B viruses (15) . However, modifications of an antibody assay that increase its sensitivity also risk increasing the occurrence of nonspecific reactions (14) .
The present studies were increased from that point more or less in parallel with those in the other two tests. In contrast to the relationship between WV HI and neutralizing titers for sera at the lower end of the spectrum, no difference existed between the neutralizing titers of sera with an ET HI titer of less than 10 and those with an ET HI titer of 10 (neutralizing GMTs of 5.2 and 6.0, respectively). Neutralizing titers were higher for sera with an ET HI titer of 20 (GMT, 14.7; range, 4 to 48), and titers in the ET HI and neutralizing tests increased more or less in parallel from that point (Fig. 1C) . The relationships of titers on group 1 sera before and after vaccination are summarized in Table 1 . The proportion of volunteers with a fourfold or greater titer rise was only 6% in the WV HI, 32% in the ET HI, and 44% in the neutralization test. Altogether, 26 (52%) of the volunteers had one or more serological responses to vaccination as follows: 3 in all three tests, 9 in both ET HI and neutralization tests, 10 in the neutralization test alone, and 4 in the ET HI test alone. Examining the serological responses to vaccination in another way, the proportion of volunteers with an ET HI titer of 80, a neutralizing titer of 32, or both increased from about 25% before vaccination to 66% afterwards. In contrast, WV HI titers as high as 20 were present in only 8% before vaccination and in 28% afterwards.
Serodiagnostic testing. The usefulness of HI tests with ET B/Singapore/222/79 for serodiagnosis of infection was compared to that with the WV antigen by using sera from groups 2, 3, 4, and 5. Among elderly persons who became ill during nursing home outbreaks of influenza B virus infection, 58% exhibited serum HI responses with ET antigen compared to 42% with WV B/Singapore/222/79 ( Caution should also be used in extrapolating the findings obtained with ET B/Singapore/222/79 to HI tests with other influenza virus strains, which may not necessarily respond in a similar manner to ether treatment (15) . Although these studies have shown that ether treatment of B/Singapore/222/79 will increase the low reactivity of this virus as an antigen in HI tests, at least some of the increased reactivity after infection appears not to be specific for B/Singapore/222/79. Further work will be necessary to define the basis for the nonspecific reactions and the situations in which they occur.
